Bayer stock jump 9% as stroke drug trial revives confidence in pipeline
Bayer shares surged on Monday after the company reported encouraging late-stage clinical trial results for its experimental cardiovascular drug asundexian, offering a rare boost for a pharmaceutical division that has…